|
|
Post by centralcoastinvestor on Jul 9, 2017 15:51:06 GMT -5
Hi my name is CCI and I'm a MannKind shareholder. (And you all are supposed to say Hi CCI!). My addiction to all things MannKind began in (gulp) 2007. I read a newspaper article about a potential game changing method of delivering insulin by inhalation. I thought to myself, if this is approved by the FDA the sky is the limit. What could go wrong?
What is the first rule of investing? Never get emotionally attached to any stock. Oops. It wasn't too long after I owned the stock and really started to understand more about diabetes that I was really hooked. I began to understand that the game changing benefits ( of what would eventually be called Afrezza) was not because it was inhaled, but because Afrezza is a highly stable form of insulin that is extremely fast in and fast out of your system. In fact, Afrezza is so good that it closely mimics the normal functioning of a pancreas in how it produces and distributes insulin in someone's body. Make no mistake, at this moment in time I still firmly believe that Afrezza is a worldwide paradigm changing form of insulin.
Will MannKind survive and Afrezza go on to become the worldwide success that Al Mann envisioned? I honestly don't know at this point. I never envisioned that MannKind would be where it is now....Betrayed by Sanofi, short on operating cash and still under relentless shorting. Could MannKind fail and go bankrupt? It is a possibility.
I'm small potatoes in terms of stock ownership compared to many of you. But if I lost all of my investment in MannKind it will hurt. So how do I feel about that? I've heard many say that they wished they had never heard of MannKind and Afrezza. I've asked myself if I feel that way. Even if I lose all my investment (I sure hope that doesn't happen), I will still feel that I have been in my own small way a part of something bigger than myself. I have learned what a scourge that diabetes is on society and hope that I never get it. My Father-In-Law was diagnosed years ago with diabetes and to this day, I still don't think he believes he has a dangerous disease. Even though his feet are a mess. I have learned that diabetes is a dangerous stealth killer. It can steal a persons eyesight, their feet and even their life through damaged organs. And yet, many can't feel the disease until years after they should have been treating it.
The idea that MannKind management doesn't have the best interest of diabetes patients or shareholders in mind is hogwash. The main obstacle for the success of Afrezza is that we are trying to change how diabetes is treated. A true paradigm shift in health care. And guess what, it turns out that it is much harder to cause large scale change than any of us expected. As a long time MannKind shareholder, I'm bummed about the value of my shares, but continue to stand strong with MannKind in the firm belief that WE will change the diabetes world for the better.
|
|
|
|
Post by sayhey24 on Jul 9, 2017 19:28:01 GMT -5
Hi CCI! You are not alone and you are among friends. The more all of us learn about diabetes the more we believe in afrezza and the better we understand why Al Mann use to run around with that laminated PK profile chart.
As CGMs become common place there will be no place for the doctors to hide. We already know most metformin users are not hitting a 7.0 A1c let alone a 5.5 target and we know nearly all see a progression in the disease. We also know early insulin intervention almost always works to stop the progression while the remaining T2 meds just make a big mess.
The bottom line is afrezza is the greatest advancement in diabetes care in 95 years. Al Mann was not wrong, CCI you are not wrong. Its a matter of time and hopefully soon we will see a positive turn for MNKD.
|
|
|
|
Post by lennymnkd on Jul 9, 2017 19:41:46 GMT -5
Hi CCI! You are not alone and you are among friends. The more all of us learn about diabetes the more we believe in afrezza and the better we understand why Al Mann use to run around with that laminated PK profile chart. As CGMs become common place there will be no place for the doctors to hide. We already know most metformin users are not hitting a 7.0 A1c let alone a 5.5 target and we know nearly all see a progression in the disease. We also know early insulin intervention almost always works to stop the progression while the remaining T2 meds just make a big mess. The bottom line is afrezza is the greatest advancement in diabetes care in 95 years. Al Mann was not wrong, CCI you are not wrong. Its a matter of time and hopefully soon we will see a positive turn for MNKD. " as CGM become more common place, there will no place for doctors to hide" gotta love it . |
|
|
|
Post by sportsrancho on Jul 9, 2017 19:49:41 GMT -5
Hi CCI, you know I've been in since 07 also. Not going anywhere:-)
Afrezza has not changed. But I'm hearing that doctors minds are. Slowly. And without the awareness I thought we needed. But I'm all for all we can get!
I'm so impressed with our key players! They are networking all the time. Getting more on board. Charles has such a big heart. You can't hide that. We lost Al but I do think he would be proud of our team!
Hey Rick this is just like roll-call of the old days:-) Love you guys, sports
|
|
|
|
Post by nadathing on Jul 9, 2017 20:18:14 GMT -5
I bought in 8 years ago because I am T2 and truly thought this was a drug that was going revolutionize how diabetes was treated and improve the quality of life for millions. And yes, I hoped to make a lot of money along the way. Lessons learned: Wall Street does not like companies where the CEO is the majority share holder. Sell when you realize a 100% gain.
I think that Al Mann was a genius, but a terrible CEO. I don't think his ego would allow someone else to run the company. I truly believed in Al, but along the way I saw the mistakes he made. I figured the beauty of Afrezza would be recognized and be a success in spite of Al's shortcomings as a CEO. I was wrong. Three years after approval and people are still struggling with titration and finding success using Afrezza to correct their BG.
I could have paid off my mortgage and all my bills 6 years ago with my original investment. I had dreams of buying a boat and a 5th wheel trailer to use in the summer to escape the harsh MN winters. Those dreams are dashed. I would feel fortunate to get half my original investment back. I do not hold out much hope for that. This hurts a lot, but I knew the risk going in and only blame myself for not selling a long time ago.
|
|
|
|
Post by falconquest on Jul 9, 2017 20:57:28 GMT -5
I bought in 8 years ago because I am T2 and truly thought this was a drug that was going revolutionize how diabetes was treated and improve the quality of life for millions. And yes, I hoped to make a lot of money along the way. Lessons learned: Wall Street does not like companies where the CEO is the majority share holder. Sell when you realize a 100% gain. I think that Al Mann was a genius, but a terrible CEO. I don't think his ego would allow someone else to run the company. I truly believed in Al, but along the way I saw the mistakes he made. I figured the beauty of Afrezza would be recognized and be a success in spite of Al's shortcomings as a CEO. I was wrong. Three years after approval and people are still struggling with titration and finding success using Afrezza to correct their BG. I could have paid off my mortgage and all my bills 6 years ago with my original investment. I had dreams of buying a boat and a 5th wheel trailer to use in the summer to escape the harsh MN winters. Those dreams are dashed. I would feel fortunate to get half my original investment back. I do not hold out much hope for that. This hurts a lot, but I knew the risk going in and only blame myself for not selling a long time ago. I think we all had dreams nadathing. I think some still do. I believe that Afrezza is a great product and can transform people's lives. Unfortunately, Mannkind has not been able to commercialize it. I don't know where this is ultimately heading but for all us dreamers, I can only hope they become reality. I'm certainly not holding my breath though. Good luck! |
|
|
|
Post by wgreystone on Jul 9, 2017 23:18:23 GMT -5
If every PWD just buys 1000 shares at this price...
|
|
|
|
Post by straightly on Jul 9, 2017 23:30:08 GMT -5
If every PWD just buys 1000 shares at this price... If every MNKD share holder gets one patient to start and stay on Afrezza... |
|
|
|
Post by omeshrin on Jul 10, 2017 0:03:23 GMT -5
I am confident in the product, and in the players that are joining to not let such an important thing die. I hope this will not be the like the electric car, because PWDs really can't wait that long.
I have no problem at all with my investment and believe in its success.
Unfortunately, it seems the sense of urgency too often happens at the last possible minute, or as they say in Europe "at 5 minutes to midnight".
I think we should not expect things to explode overnight, even with DTC. Like everything, it takes relentless work and effort from multiple fronts.
It'll happen.
Thank you for sharing your story =)
|
|
|
|
Post by buyitonsale on Jul 10, 2017 1:37:21 GMT -5
If I had diabetes I would use Afrezza if I knew about it.
Just 20K patients in US or ~ 80K patients outside US
Is all that is needed to sustain this company.
So, once real advertising in US starts or one international deal is closed the longs saga will end and shorts saga will begin.
|
|
|
|
Post by promann on Jul 10, 2017 7:18:55 GMT -5
Hey CCI, Nice post and I also have to say we are in the same boat. I started investing in MNKD about 6 years ago when it was pinned at 3.00 SP for months. I started small and then after adcom I went big rode it up to over 10.00 when I was convinced it would go a lot higher. Then we partnered with Sanofi and that was our spiral down. I think some how the shorts knew Sanofi was going to sabotage Afrezza it just did not make sense how confident they were.
Anyways I have been fortunate enough to be able to average down enough, where some may have been all in and may have had to sell at losses to cover unexpected expenses. I feel really bad for them, and I hope they were able to get back in .
I am confident that MNKD will succeed and we are at a point when all the pieces will come together in the next few months. It's all about time money and runway and we will get it I have no worries what so ever. Just hold on and don't stress out over the short term deflated SP it's only temporary and time will prove Afrezzas success. It always seems like we are waiting for something big to raise the stock price month over month but if you think about it MNKD is just getting started only 1 year old it's all coming together. Good luck everyone.
And sports I do remember the roll call. I'm still here not going anywhere;-)
|
|
|
|
Post by nadathing on Jul 10, 2017 7:20:15 GMT -5
If I had diabetes I would use Afrezza if I knew about it. Just 20K patients in US or ~ 80K patients outside US Is all that is needed to sustain this company. So, once real advertising in US starts or one international deal is closed the longs saga will end and shorts saga will begin. I have diabetes. My A1c is 5.7 and controlled through diet, exercise and medication. I take Metformin (500 mg) twice a day and a weekly shot of a GLP-1. For me, inhaling 3 or more times a day doesn't make any sense. I am fully aware of the health risks of my current regiment and accept it. There are many T2's like me. I don't believe we are the real market for Afrezza. I also think that converting adults with T1 is an uphill battle. Teaching an old dog a new trick isn't that easy. I don't think many have the patience to experiment with dosing and after not seeing immediate results, they decide to stop using Afrezza. The real market, IMO, is juvenile T1's. Put Afrezza and OneDrop in a young persons hands and you will see success. They love technology and the simplicity of Afrezza. I believe they would consider it cool to use. Problem is, where are we with approval for juvenile T1's? |
|
|
|
Post by akemp3000 on Jul 10, 2017 7:50:29 GMT -5
It's understandably hard to change inertia for T2s who are already on a regimen but for early and new T2s, why would anyone choose a GLP-1 shot and Metformin with health risks versus starting on Afrezza to keep their A1c down? Just asking to learn.
|
|
|
|
Post by derek2 on Jul 10, 2017 8:09:14 GMT -5
It's understandably hard to change inertia for T2s who are already on a regimen but for early and new T2s, why would anyone choose a GLP-1 shot and Metformin with health risks versus starting on Afrezza to keep their A1c down? Just asking to learn. If you're asking to learn, then here are a few reasons (Answering as a T2 for 17 years. Currently well controlled (A1C 6.2) on Metformin, Forxiga and Basal & Mealtime insulin.) 1. Because after diet and exercise, Metformin is what most doctors recommend, adding a second therapy (in this case GLP-1) if necessary. 2. If that works, your doctor will not want to change. 3. Metformin is quite safe and well tolerated, despite some rather tin foil claims to the contrary 'round here. Insulin has far more health risk, regardless of administration route (hypo, weight gain, increased LDL, increased BP) than Metformin, and initiating insulin therapy can impact your ability to obtain or retain life insurance. Obviously, it's eventually necessary for many T2s, but where applicable, therapies like Metformin that increase insulin sensitivity allow the body to properly regulate blood glucose instead of the blunt tool of exogenous insulin. |
|
|
|
Post by kball on Jul 10, 2017 8:14:32 GMT -5
Mine wasnt so much complicated, as it was abusive.
I ended up leaving. Just not before i went all in.
Multiple buys over 6 months, loaning shares, thinking i cant possibly be wrong.
Etc.
|
|
